期刊文献+

EB病毒性肝炎40例临床分析 被引量:3

Clinical analysis of 40 patients with EB viral hepatitis
下载PDF
导出
摘要 目的探讨EB病毒性肝炎的临床表现、疗效及预后。方法回顾性分析40例住院EB病毒性肝炎患者的临床资料,将患者分为单一EB病毒性肝炎组18例和EB病毒性肝炎合并其他原因肝损害组22例,总结2组的临床特点。结果EB病毒性肝炎主要临床表现为乏力、食欲下降、黄疸、肝脾肿大,及不同程度损害。合并肝炎组总胆红素(TBIL)、谷丙转氨酶(ALT)及谷草转氨酶(AST)水平显著高于单一EB病毒性肝炎组(P<0.05)。结论 EB病毒感染是肝功能损害原因之一。 Objective To investigate the clinical manifestation, curative effect and progno- sis of patients with EB viral hepatitis. Methods Clinical data of 40 hospitalized patients with EB vi- ral hepatitis was retrospectively analyzed. The patients were divided into single EB viral hepatitis group (n = 18 ) and EB viral hepatitis complicated with other liver damage group (n = 22). The clin- ical characteristics were summarized. Results The main clinical manifestations of patients with EB viral hepatitis were fatigue, anorexia, jaundice, hepatosplenomegaly, and different degrees of damage. Levels of serum total bilirubin (TBIL), alanine aminotransferase (ALT) and aspartate amin- otransferase (AST) in EB viral hepatitis complicated with other liver damage group were significantly higher than those in single EB viral hepatitis group (P 〈 0.05 ). Conclusion EB virus infection is one of the causes of liver function damage.
出处 《实用临床医药杂志》 CAS 2018年第5期23-25,共3页 Journal of Clinical Medicine in Practice
关键词 EB病毒 肝炎 临床特点 筛查 总胆红素 谷丙转氨酶 谷草转氨酶 EB virus hepatitis clinical characteristics screening total bilirubin alanine aminotransferase aspartate aminotransferase
  • 相关文献

参考文献8

二级参考文献113

  • 1孙雪颖,梅全喜,周小军,高玉桥.中药的抗EB病毒作用研究进展[J].中药材,2008,31(2):320-322. 被引量:20
  • 2谢正德,申昆玲.重视儿童非肿瘤性EB病毒感染疾病的研究[J].首都医科大学学报,2010,31(2):213-216. 被引量:43
  • 3刘晓红,叶树清,张忠浩,刘力戈,杨春霞,郑杨,王新佳,詹少兵,王琦,周玲.热毒净在体外对EB病毒抗原表达的抑制作用[J].中国实验方剂学杂志,2007,13(10):62-63. 被引量:4
  • 4彭向欣,王泰龄.EB病毒性肝炎.肝脏疾病临床病理学.北京:化学工业出版社,2010:118-126.
  • 5Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003; 187: 527-533 [PMID: 12599068 DOI: 10.1086/367988].
  • 6Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011; 117: 5835-5849 [PMID: 21454450 DOI: 10.1182/blood-2010-11-316745].
  • 7Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 2005; 191: 531-539 [PMID: 15655776].
  • 8Suh N, Liapis H, Misdraji J, Brunt EM, Wang HL. Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients. Am J Surg Pathol 2007; 31: 1403-1409 [PMID: 17721196 DOI: 10.1097/ P AS.Ob013e31802ffdd5].
  • 9Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005; 80: 64-69 [PMID: 16138335 DOI: 10.1002/ajh.20398].
  • 10Kimura H, Hoshino Y, Kanegane H, Tsuge 1, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active EpsteinBarr virus infection. Blood 2001; 98: 280-286 [PMID: 11435294].

共引文献344

同被引文献42

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部